Stephen Liu
MD
Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics
Georgetown Lombardi Comprehensive Cancer Center
Dec 30, 2024
Episode
269
Soundcloud
Share
In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a discussion on the FDA approval of perioperative nivolumab based on the Phase III CheckMate 77T study. Perioperative therapy has improved outcomes in patients with resectable NSCLC and is emerging as best practice, but there is nuance to the delivery of this therapy.
Guest
Tina Cascone
MD
Associate Professor, Department of Thoracic/Head and Neck Medical Oncology
The University of Texas MD Anderson Cancer Center
Shun Lu
MD.
Chief
Shanghai Chest Hospital
Shanghai Lung Cancer Center
Professor at Shanghai Jiaotong University
Executive Board Member of the Chinese Society of Clinical Oncology
Past Chair of Chinese Lung Cancer Association
